Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel camphor-based ionic liquids enable high-yield esterification. Green synthesis route offers cost reduction and supply reliability for pharma intermediates.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity triazole intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN111454226B reveals a novel FeCl3-catalyzed one-pot synthesis of symmetrical triazines from aromatic aldehydes, offering significant cost reduction in fine chemical manufacturing.
Patent CN110724080B details a green electrochemical route using arylboronic acids, offering high yields and reduced costs for pharmaceutical intermediate manufacturing.
Patent CN111423381A details a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering high yields and broad substrate tolerance for pharmaceutical manufacturing.
Patent CN108610304B details a novel Pd-catalyzed C-H activation route for diaryl sultams, offering superior atom economy and simplified supply chains for pharmaceutical intermediates.
New one-step synthesis route for indole carbazoles reduces costs and improves scalability for pharmaceutical intermediate manufacturing supply chains.
Novel Pd-catalyzed carbonylation route offers high yields and broad substrate scope for drug molecule synthesis, ensuring reliable supply chain solutions.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN113307778A details a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate suppliers.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN111592507A reveals a metal-free route to polysubstituted furans using BF3 catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115197124B reveals mild ammonium iodide catalysis for pyridine derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110590621B details a mild copper-catalyzed route for 1,2-bis(arylsulfonyl) ethylene derivatives, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN111410656B details a novel copper-catalyzed route to isoquinolinones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production capabilities.
Novel palladium-catalyzed route for 3-alkynylbenzofuran compounds ensures high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Novel carbonylation method avoids toxic thiols using sulfonyl chlorides. High yield, scalable process ideal for reliable pharmaceutical intermediate manufacturing.
Novel Rhodium-catalyzed method for trifluoromethyl enaminones offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing and drug discovery.
Patent CN114539198A details a novel Pd-catalyzed route to isochroman amides using nitroarenes, offering safer scale-up and cost reduction in pharmaceutical intermediate manufacturing.